SEI Investments’s CorMedix CRMD Stock Holding History

SEI Investments’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$282K	Sell	35,905 -66,939	-65%	-$529K	﹤0.01%	2897
2026 Q1	$698K	Buy	102,844 +46,557	+83%	+$344K	﹤0.01%	2525
2025 Q4	$655K	Buy	56,287 +34,694	+161%	+$384K	﹤0.01%	2388
2025 Q3	$251K	Sell	21,593 -20,075	-48%	-$243K	﹤0.01%	2533
2025 Q2	$513K	Buy	+41,668	New	+$460K	﹤0.01%	2174
2018 Q3	–	Sell	-2,739	Closed	-$3K	–	2647
2018 Q2	$3K	Buy	+2,739	New	+$3.17K	﹤0.01%	3259
2015 Q4	–	Sell	-1,220	Closed	-$12K	–	2540
2015 Q3	$12K	Buy	+1,220	New	+$18.8K	﹤0.01%	2152

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SEI Investments's CRMD Position: Q2 2026 in Review

SEI Investments reduced its CorMedix (CRMD) stake by 65% in Q2 2026, selling an estimated $529K and leaving 35,905 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #2897.

SEI Investments first reported a position in CRMD in Q3 2015 and has held it in 7 quarters since. The position peaked at $698K in Q1 2026. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

SEI Investments held 35,905 shares of CorMedix worth $282K as of Q2 2026.
SEI Investments sold 66,939 CorMedix shares in Q2 2026, an estimated $529K.
CorMedix made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2897 holding.
SEI Investments first reported a position in CorMedix in Q3 2015 and has held it in 7 quarters since.
SEI Investments's CorMedix position peaked at $698K in Q1 2026.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.